HRSA Defends 340B Orphan Drug Rule

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Health Resources and Services Administration said it stands by its interpretation of the Affordable Care Act orphan drug exclusion, despite a recent court ruling that challenged its authority to engage in legislative rulemaking.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

Tessa Vellek
Tessa Vellek

Login